This review summarises treatments for atopic dermatitis which are shifting toward more targeted and precise interventions. Dr Chih-ho Hong and Professor John Su present on these topics, with a focus on clinical trial support for lebrikizumab. Real-life patient case studies are also provided.
Please login below to download this issue (PDF)